[ad_1] 29/10/2018 QIAGEN N.V. (NYSE: QGEN, Frankfurt Prime Standard: QIA) announced today the Third quarter and third quarter operating results first nine months 2018 known. According to the data, progress has been …
Read More »QIAGEN wins with QuantiFERON-TB® Gold Plus offered by the UN Migration Board
[ad_1] 30.07.2018 QIAGEN N.V. (NYSE: QEN: Frankfurt Prime Standard: QIA) released today known to be QuantiFERON-TB ® Gold Plus (QFT-Plus), the Gold standard for accurate and cost effective tests on latent Tuberculosis …
Read More »